Advances in Technology in the Addiction Profession: Digital Therapeutics - Clinically Validated Behavioral Treatments for Substance Use Disorders

Recorded on Friday, July 23, 2021 

A Recorded Webinar

Register to Watch: On-Demand Recording
Download: PowerPoint Slides 
CE Credit: Online CE Quiz 
InstructionsAccess to Online CE Quiz and Certificate Instructions
Transcript: Closed Captioning Transcript 
Reference List: Presentation References 
Answers: Live Event Q & A (coming soon...)
Agenda: Webinar Agenda

There are effective treatments for substance use disorders (SUDs), though they do not work for all patients and efficacy decreases over the long-term. Thus, there is an urgent need for new therapeutic options. This workshop will highlight research to support the development of safe and effective digital therapeutics (DTx), discuss strategies to accelerate their delivery to patients, and improve SUD treatment outcomes. DTx, a subset of digital health, consists of high-quality software programs to prevent, manage, or treat medical conditions. DTx that meet the definition of a medical device go through an FDA regulatory review process to be legally marketed in the US. The ultimate goal of this workshop is to illuminate NIH-supported and FDA-authorized DTx options for patients with SUDs.


Will M. Aklin, PhD, is director of the Behavioral Therapy Development Program within the Division of Therapeutics and Medical Consequences at the National Institute on Drug Abuse (NIDA). He received his Doctoral degree in Clinical Psychology from the University of Maryland. Aklin’s areas of research include development of treatments with theory-derived behavioral targets; studies that integrate behavioral/pharmacological treatment, and clinical validation/optimization of digital therapeutic interventions. Aklin has extensive experience in behavioral and cognitive-behavioral treatment for substance use disorders, adaptive brief interventions, and adherence trials. He has coordinated several National Institute of Health flagship initiatives, including partnering with the National Institute on Alcohol Abuse and Alcoholism and NCI on the development and testing of behavioral therapies for substance use disorders, common fund initiatives, Helping to End Addiction Long-term (HEAL) initiative, and partnerships with the Food and Drug Administration (FDA) on digital therapeutics and device-based treatments for substance use disorders.

Learning Objectives
  • Participants will be able to discern which technologies constitute digital therapeutics.
  • Participants will be able to describe digital therapeutics as stand-alone treatments or integrated with FDA-approved substance use disorder treatments.
  • Participants will be able to summarize the FDA authorization process for digital therapeutics.
Content Level


  • Beginning level courses introduce learners to a content area; include information about a condition, treatment method, or issue; and involve learning and comprehending content.

Polls and Q&A

Earn Continuing Education Hours (CEs)

A Certificate of Completion for 1.5 CEs is available by participating in this specialty online training and passing an online CE quiz. Those who successfully complete the full series and pass all seven CE quizzes for this seven-part series will be eligible to apply for the Certificate of Achievement for Advances in Technology in the Addiction Profession. Access to the online CE quiz will be in your NAADAC profile after registration. 

Click here for a complete list of organizations who approve NAADAC to provide continuing education hours.
This webinar is eligible for ASWB ACE CE hours. Click here for NAADAC Social Worker certificate instructions. 
This course meets the qualifications for one and a half (1.5) hours of continuing education credit for LMFTs, LCSWs, LPCCs, and/or LEPs as required by the California Board of Behavioral Sciences.


Receive 1.5 CEs for $25.

Who Should Attend

Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters and how to incorporate technology into treatment and recovery.


Live closed captioning is available and the captioning capabilities are in compliance with the practices defined in Worldwide Web Consortium’s (W3C) Web Content Accessibility Guidelines (WCAG) and Section 508 of the Rehabilitation Act. In addition, transcripts are available for on-demand webinars recorded on and after March 27, 2019.

Questions, comments, or concerns about NAADAC Education? Take a look at our Webinar FAQs or email NAADAC.

Click here to learn about system requirements for NAADAC Webinars.

This presentation is for individual use only and may not be reproduced without permission from NAADAC.